Zobrazeno 1 - 10 of 86 pro vyhledávání: '"Mark Tann"'
1
Akademický článek
The impact of sestamibi scan on clinical decision-making for renal masses: An observational single-center study
Autor: Courtney Yong, Yan Tong, Mark Tann, Chandru P. Sundaram
Publikováno v: Indian Journal of Urology (2024)
Introduction: We aimed to determine whether sestamibi scan changes management of renal masses. Methods: All patients undergoing sestamibi scan for renal masses between 2008 and 2022 at a single center were retrospectively reviewed. Data were gathered
Externí odkaz: https://doaj.org/article/b5f0dcc025eb4832bd487eba3c90e6d7
Zobrazit plný text záznamu
2
Akademický článek
Comparison of tracer kinetic models for 68Ga-PSMA-11 PET in intermediate-risk primary prostate cancer patients
Autor: Nathaniel J. Smith, Mark A. Green, Clinton D. Bahler, Mark Tann, Wendy Territo, Anne M. Smith, Gary D. Hutchins
Publikováno v: EJNMMI Research, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Background 68Ga-PSMA-11 positron emission tomography enables the detection of primary, recurrent, and metastatic prostate cancer. Regional radiopharmaceutical uptake is generally evaluated in static images and quantified as standard uptake v
Externí odkaz: https://doaj.org/article/06a0748e99e9478a9d938c542dd93b18
Zobrazit plný text záznamu
3
Akademický článek
Non-alcoholic fatty liver disease is not associated with impairment in health-related quality of life in virally suppressed persons with human immune deficiency virus.
Autor: Samer Gawrieh, Kathleen E Corey, Jordan E Lake, Niharika Samala, Archita P Desai, Paula Debroy, Julia A Sjoquist, Montreca Robison, Mark Tann, Fatih Akisik, Surya S Bhamidipalli, Chandan K Saha, Kimon Zachary, Gregory K Robbins, Samir K Gupta, Raymond T Chung, Naga Chalasani
Publikováno v: PLoS ONE, Vol 18, Iss 2, p e0279685 (2023)
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in persons with HIV (PWH) (HIV-NAFLD). It is unknown if HIV-NAFLD is associated with impairment in health-related quality of life (HRQOL). We examined HRQOL in PWH with and wi
Externí odkaz: https://doaj.org/article/50cb0378014b48f99390ce45308ec5c7
Zobrazit plný text záznamu
4
Akademický článek
Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma
Autor: Lauren M. Ladd, Temel Tirkes, Mark Tann, David M. Agarwal, Matthew S. Johnson, Bilal Tahir, Kumaresan Sandrasegaran
Publikováno v: Clinical and Molecular Hepatology, Vol 22, Iss 4, Pp 450-457 (2016)
Background/Aims The diagnosis and treatment plan for hepatocellular carcinoma (HCC) can be made from radiologic imaging. However, lesion detection may vary depending on the imaging modality. This study aims to evaluate the sensitivities of hepatic mu
Externí odkaz: https://doaj.org/article/327829ef622144fdae0724fbf7adfc23
Zobrazit plný text záznamu
9
Highly variable biodistribution of
Autor: Monica, Cheng, Mark, Tann
Publikováno v: Hepatobiliary surgery and nutrition. 11(5)
Somatostatin receptor (SSTR)-targeted positron emission tomography/computed tomography (PET/CT) imaging has risen to the forefront for neuroendocrine tumor (NET) detection and management, yet the variability of significant uptake variability (SUV) as
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2a3323846cf4d732336e779bf3323043
https://pubmed.ncbi.nlm.nih.gov/36268247
Zobrazit plný text záznamu
10
[68Ga]Ga-P16-093 as a PSMA-Targeted PET Radiopharmaceutical for Detection of Cancer: Initial Evaluation and Comparison with [68Ga]Ga-PSMA-11 in Prostate Cancer Patients Presenting with Biochemical Recurrence
Autor: Mark Tann, Hank F. Kung, William C. Eckelman, David Alexoff, James W. Fletcher, Mark A. Green, Justin Sims, Clinton D. Bahler, Gary D. Hutchins, Wendy Territo, Heather Polson, Carla J. Mathias
Publikováno v: Molecular Imaging and Biology. 22:752-763
This study was undertaken to evaluate radiation dosimetry for the prostate-specific membrane antigen targeted [68Ga]Ga-P16-093 radiopharmaceutical, and to initially assess agent performance in positron emission tomography (PET) detection of the site
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8d6566b4d1c4a5d2866e7ba9ff9609eb
https://doi.org/10.1007/s11307-019-01421-7
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje